Drug Testing Market (By Product: Consumables, Instruments, Rapid Testing Devices, Services; By Sample Type: Urine Samples, Oral Fluid Samples, Hair Samples, Other Samples; By Drug Type: Alcohol, Cannabis/Marijuana, Cocaine, Opioids, Amphetamine & Methamphetamine, LSD, Others; By End-use: Drug Testing Laboratories, Workplaces, Hospitals, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 20212030

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Drug Testing Market, By Product Type

7.1.  Drug Testing Market, by Product Type, 2020-2030

7.1.1.    Consumables

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Instruments

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Rapid Testing Devices

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Services

7.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Drug Testing Market, By Sample Type

8.1.  Drug Testing Market, by Sample Type, 2020-2030

8.1.1.    Urine Samples

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Oral Fluid Samples

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Hair Samples

8.1.3.1.        Market Revenue and Forecast (2016-2030)

8.1.4.    Other Samples

8.1.4.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Drug Testing Market, By Drug Type

9.1.  Drug Testing Market, by Drug Type, 2020-2030

9.1.1.    Alcohol

9.1.1.1.        Market Revenue and Forecast (2016-2030)

9.1.2.    Cannabis/Marijuana

9.1.2.1.        Market Revenue and Forecast (2016-2030)

9.1.3.    Cocaine

9.1.3.1.        Market Revenue and Forecast (2016-2030)

9.1.4.    Opioids

9.1.4.1.        Market Revenue and Forecast (2016-2030)

9.1.5.    Amphetamine & Methamphetamine

9.1.5.1.        Market Revenue and Forecast (2016-2030)

9.1.6.    LSD

9.1.6.1.        Market Revenue and Forecast (2016-2030)

9.1.7.    Others

9.1.7.1.        Market Revenue and Forecast (2016-2030)

Chapter 10.      Global Drug Testing Market, By End-use

10.1.        Drug Testing Market, by End-use, 2020-2030

10.1.1.  Drug Testing Laboratories

10.1.1.1.      Market Revenue and Forecast (2016-2030)

10.1.2.  Workplaces

10.1.2.1.      Market Revenue and Forecast (2016-2030)

10.1.3.  Hospitals

10.1.3.1.      Market Revenue and Forecast (2016-2030)

10.1.4.  Others

10.1.4.1.      Market Revenue and Forecast (2016-2030)

Chapter 11.      Global Drug Testing Market, Regional Estimates and Trend Forecast

11.1.        North America

11.1.1.  Market Revenue and Forecast, by Product Type (2016-2030)

11.1.2.  Market Revenue and Forecast, by Sample Type (2016-2030)

11.1.3.  Market Revenue and Forecast, by Drug Type (2016-2030)

11.1.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.1.5.  U.S.

11.1.5.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.1.5.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.1.5.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.1.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.1.6.  Rest of North America

11.1.6.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.1.6.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.1.6.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.1.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.        Europe

11.2.1.  Market Revenue and Forecast, by Product Type (2016-2030)

11.2.2.  Market Revenue and Forecast, by Sample Type (2016-2030)

11.2.3.  Market Revenue and Forecast, by Drug Type (2016-2030)

11.2.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.2.5.  UK

11.2.5.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.2.5.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.2.5.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.2.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.6.  Germany

11.2.6.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.2.6.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.2.6.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.2.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.7.  France

11.2.7.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.2.7.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.2.7.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.2.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.2.8.  Rest of Europe

11.2.8.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.2.8.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.2.8.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.2.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.        APAC

11.3.1.  Market Revenue and Forecast, by Product Type (2016-2030)

11.3.2.  Market Revenue and Forecast, by Sample Type (2016-2030)

11.3.3.  Market Revenue and Forecast, by Drug Type (2016-2030)

11.3.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.3.5.  India

11.3.5.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.3.5.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.3.5.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.3.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.6.  China

11.3.6.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.3.6.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.3.6.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.3.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.7.  Japan

11.3.7.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.3.7.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.3.7.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.3.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.3.8.  Rest of APAC

11.3.8.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.3.8.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.3.8.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.3.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.        MEA

11.4.1.  Market Revenue and Forecast, by Product Type (2016-2030)

11.4.2.  Market Revenue and Forecast, by Sample Type (2016-2030)

11.4.3.  Market Revenue and Forecast, by Drug Type (2016-2030)

11.4.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.4.5.  GCC

11.4.5.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.4.5.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.4.5.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.4.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.6.  North Africa

11.4.6.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.4.6.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.4.6.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.4.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.7.  South Africa

11.4.7.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.4.7.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.4.7.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.4.7.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.4.8.  Rest of MEA

11.4.8.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.4.8.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.4.8.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.4.8.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.5.        Latin America

11.5.1.  Market Revenue and Forecast, by Product Type (2016-2030)

11.5.2.  Market Revenue and Forecast, by Sample Type (2016-2030)

11.5.3.  Market Revenue and Forecast, by Drug Type (2016-2030)

11.5.4.  Market Revenue and Forecast, by End-use (2016-2030)

11.5.5.  Brazil

11.5.5.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.5.5.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.5.5.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.5.5.4.      Market Revenue and Forecast, by End-use (2016-2030)

11.5.6.  Rest of LATAM

11.5.6.1.      Market Revenue and Forecast, by Product Type (2016-2030)

11.5.6.2.      Market Revenue and Forecast, by Sample Type (2016-2030)

11.5.6.3.      Market Revenue and Forecast, by Drug Type (2016-2030)

11.5.6.4.      Market Revenue and Forecast, by End-use (2016-2030)

Chapter 12.  Company Profiles

12.1.              Quest Diagnostics Incorporated

12.1.1.  Company Overview

12.1.2.  Product Offerings

12.1.3.  Financial Performance

12.1.4.  Recent Initiatives

12.2.              Abbott Laboratories

12.2.1.  Company Overview

12.2.2.  Product Offerings

12.2.3.  Financial Performance

12.2.4.  Recent Initiatives

12.3.              Quidel Corporation

12.3.1.  Company Overview

12.3.2.  Product Offerings

12.3.3.  Financial Performance

12.3.4.  Recent Initiatives

12.4.              F. Hoffmann-La Roche

12.4.1.  Company Overview

12.4.2.  Product Offerings

12.4.3.  Financial Performance

12.4.4.  Recent Initiatives

12.5.              Thermo Fisher Scientific, Inc.

12.5.1.  Company Overview

12.5.2.  Product Offerings

12.5.3.  Financial Performance

12.5.4.  Recent Initiatives

12.6.              Siemens Healthineers

12.6.1.  Company Overview

12.6.2.  Product Offerings

12.6.3.  Financial Performance

12.6.4.  Recent Initiatives

12.7.              Bio-Rad Laboratories, Inc.

12.7.1.  Company Overview

12.7.2.  Product Offerings

12.7.3.  Financial Performance

12.7.4.  Recent Initiatives

12.8.              Agilent Technologies, Inc.

12.8.1.  Company Overview

12.8.2.  Product Offerings

12.8.3.  Financial Performance

12.8.4.  Recent Initiatives

12.9.              LabCorp

12.9.1.  Company Overview

12.9.2.  Product Offerings

12.9.3.  Financial Performance

12.9.4.  Recent Initiatives

12.10.           Drägerwerk AG & CO. KGaA

12.10.1.               Company Overview

12.10.2.               Product Offerings

12.10.3.               Financial Performance

12.10.4.               Recent Initiatives

12.11.           Clinical Reference Laboratory (CRL), Inc.

12.11.1.               Company Overview

12.11.2.               Product Offerings

12.11.3.               Financial Performance

12.11.4.               Recent Initiatives

12.12.           Cordant Health Solutions

12.12.1.               Company Overview

12.12.2.               Product Offerings

12.12.3.               Financial Performance

12.12.4.               Recent Initiatives

12.13.           Legacy Medical Services, LLC

12.13.1.               Company Overview

12.13.2.               Product Offerings

12.13.3.               Financial Performance

12.13.4.               Recent Initiatives

12.14.           Omega Laboratories, Inc.

12.14.1.               Company Overview

12.14.2.               Product Offerings

12.14.3.               Financial Performance

12.14.4.               Recent Initiatives

Chapter 13.  Research Methodology

13.1.              Primary Research

13.2.              Secondary Research

13.3.              Assumptions

Chapter 14.  Appendix

14.1.              About Us

Glossary of Terms